MIM
AFMD

MetLife Investment Management’s Affimed AFMD Stock Holding History

MetLife Investment Management’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,190
Closed -$27.2K – 2788
2022
Q4 		$27.2K Sell
2,190
-5,435
-71% -$95.4K ﹤0.01% 2802
2022
Q3 		$157K Buy
7,625
+2,855
+60% +$79.4K ﹤0.01% 2444
2022
Q2 		$132K Sell
4,770
-936
-16% -$32K ﹤0.01% 2572
2022
Q1 		$249K Buy
5,706
+2,967
+108% +$129K ﹤0.01% 2222
2021
Q4 		$151K Sell
2,739
-1,424
-34% -$88K ﹤0.01% 2229
2021
Q3 		$257K Buy
4,163
+1,109
+36% +$73K ﹤0.01% 1924
2021
Q2 		$260K Sell
3,054
-1,430
-32% -$130K ﹤0.01% 1987
2021
Q1 		$355K Buy
4,484
+2,156
+93% +$140K ﹤0.01% 1720
2020
Q4 		$135K Buy
2,328
+1,123
+93% +$52.9K ﹤0.01% 2167
2020
Q3 		$40.9K Sell
1,205
-2,382
-66% -$90.2K ﹤0.01% 2270
2020
Q2 		$166K Buy
+3,587
New +$99.8K ﹤0.01% 2007
2019
Q4 		– Sell
-3,269
Closed -$96.1K – 2302
2019
Q3 		$96.1K Buy
+3,269
New +$97.3K ﹤0.01% 2310

Other funds holding AFMD

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPSPJS
General Pension Society PZU Joint Stock Warsaw, Poland $654M AUM 55.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MetLife Investment Management's AFMD Position: Q1 2023 in Review

MetLife Investment Management sold out of Affimed (AFMD) in Q1 2023, closing a stake of 2,190 shares — an estimated $27.2K sold.

MetLife Investment Management first reported a position in AFMD in Q3 2019 and held it in 12 quarters. The position peaked at $355K in Q1 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • MetLife Investment Management reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 2,190 Affimed shares in Q1 2023, an estimated $27.2K.
  • MetLife Investment Management first reported a position in Affimed in Q3 2019 and held it in 12 quarters.
  • MetLife Investment Management's Affimed position peaked at $355K in Q1 2021.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.